Ulster University Logo

Ulster Institutional Repository

Insulin-releasing action of the novel antidiabetic agent BTS 67 582

Biomedical Sciences Research Institute Computer Science Research Institute Environmental Sciences Research Institute Nanotechnology & Advanced Materials Research Institute

McClenaghan, Neville, Flatt, Peter and Bailey, CJ (1998) Insulin-releasing action of the novel antidiabetic agent BTS 67 582. BRITISH JOURNAL OF PHARMACOLOGY, 123 (3). pp. 400-404. [Journal article]

Full text not available from this repository.

Abstract

1 BTS 67 582 (1,1-dimethyl-2-(2-morpholinophenyl)guan fumarate) is a novel antidiabetic agent with a short-acting insulin-releasing effect. This study examined its mode of action in the clonal B-cell line BRIN-BD11. 2 BTS 67 582 increased insulin release from BRIN-BD11 cells in a concentration-dependent manner (10(-8) to 10(-4) M) at both non-stimulating (1.1 mM) and stimulating (16.7 mM) concentrations of glucose. 3 BTS 67 582 (10(-4) M) potentiated the insulin-releasing effect of a depolarizing concentration of K+ (30 mM), whereas the K+ channel openers pinacidil (400 mu M) and diazoxide (300 mu M) inhibited BTS 67 582-induced release. 4 Suppression of Ca+ channel activity with verapamil (20 mu M) reduced the insulin-releasing effect of BTS 67 582 (10(-4) M). 5 BTS 67 582 (10(-4) M) potentiated insulin release induced by amino acids (10 mM), and enhanced the combined stimulant effects of glucose plus either the fatty acid palmitate (10 mM). or agents which raise intracellular cyclic AMP concentrations (25 mu M forskolin and 1 mM isobutylmethylxanthine), or the cholinoceptor agonist carbachol (100 mu M). 6 Inhibition of glucose-stimulated insulin release by adrenaline or noradrenaline (10 mu M) was partially reversed by BTS 67 582 (10(-4) M). 7 These data suggest that the insulin-releasing effect of BTS 67 582 involves regulation of ATP-sensitive K+ channel activity and Ca2+ influx, and that the drug augments the stimulant effects of nutrient insulin secretagogues and agents which enhance adenylate cyclase and phospholipase C. BTS 67 582 may also exert insulin-releasing effects independently of ATP-sensitive K+ channel activity.

Item Type:Journal article
Faculties and Schools:Faculty of Life and Health Sciences
Faculty of Life and Health Sciences > School of Biomedical Sciences
Research Institutes and Groups:Biomedical Sciences Research Institute
Biomedical Sciences Research Institute > Diabetes
ID Code:3135
Deposited By:Professor Peter Flatt
Deposited On:08 Jan 2010 14:01
Last Modified:15 Jun 2011 11:10

Repository Staff Only: item control page